These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6190183)

  • 1. The Leeuwenhoek lecture, 1982. Studies of microbial products in rising to the challenge of curing cancer.
    Umezawa H
    Proc R Soc Lond B Biol Sci; 1983 Mar; 217(1209):357-76. PubMed ID: 6190183
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunomodulation by cancer chemotherapeutic agents and antineoplastic activity.
    Spreafico F; Mantovani A
    Pathobiol Annu; 1981; 11():177-95. PubMed ID: 6460217
    [No Abstract]   [Full Text] [Related]  

  • 3. Regulatory T cells, tumour immunity and immunotherapy.
    Zou W
    Nat Rev Immunol; 2006 Apr; 6(4):295-307. PubMed ID: 16557261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T regulatory cells, the evolution of targeted immunotherapy.
    Nizar S; Meyer B; Galustian C; Kumar D; Dalgleish A
    Biochim Biophys Acta; 2010 Aug; 1806(1):7-17. PubMed ID: 20188145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory T cells, as a target in anticancer immunotherapy.
    Enokida T; Nishikawa H
    Immunotherapy; 2017 Jun; 9(8):623-627. PubMed ID: 28653572
    [No Abstract]   [Full Text] [Related]  

  • 6. [Combined use of bleomycin and radiation].
    Terashima T
    Nihon Ishikai Zasshi; 1969 Jul; 62(2):142-4. PubMed ID: 5388430
    [No Abstract]   [Full Text] [Related]  

  • 7. Microbial secondary metabolites with potential use in cancer treatment. (Plasmid involvement in biosynthesis and compounds.
    Umezawa H
    Biomedicine; 1977 Jul; 26(4):236-49. PubMed ID: 72569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination cancer therapy: Presidential address.
    Frei E
    Cancer Res; 1972 Dec; 32(12):2593-607. PubMed ID: 4118763
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunosuppression by Treg can be decreased with anti-GARP antibodies].
    Lucas S
    Med Sci (Paris); 2015 Oct; 31(10):832-4. PubMed ID: 26481020
    [No Abstract]   [Full Text] [Related]  

  • 10. Does chemotherapy augment anti-tumor immunotherapy by preferential impairment of regulatory T cells?
    Zhang L; Dermawan KT; Jin ML; Xiong SD; Chu YW
    Med Hypotheses; 2008 Nov; 71(5):802-4. PubMed ID: 18691831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bleomycin-induced over-replication involves sustained inhibition of mitotic entry through the ATM/ATR pathway.
    Nakayama Y; Igarashi A; Kikuchi I; Obata Y; Fukumoto Y; Yamaguchi N
    Exp Cell Res; 2009 Sep; 315(15):2515-28. PubMed ID: 19527713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor antibiotics and low molecular weight immunomodifiers of microbial origin.
    Umezawa H
    Cancer Treat Rep; 1984 Jan; 68(1):137-44. PubMed ID: 6692425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory T cells: a new frontier in cancer immunotherapy.
    Barnett BG; Rüter J; Kryczek I; Brumlik MJ; Cheng PJ; Daniel BJ; Coukos G; Zou W; Curiel TJ
    Adv Exp Med Biol; 2008; 622():255-60. PubMed ID: 18546633
    [No Abstract]   [Full Text] [Related]  

  • 14. [Molecular mechanisms of the action of anticancer antibiotics].
    Gauze GF; Dudnik IuV
    Vestn Akad Med Nauk SSSR; 1979; (8):73-9. PubMed ID: 91276
    [No Abstract]   [Full Text] [Related]  

  • 15. Targeting regulatory T cells in tumors.
    Liu C; Workman CJ; Vignali DA
    FEBS J; 2016 Jul; 283(14):2731-48. PubMed ID: 26787424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New strategies for cancer immunotherapy: targeting regulatory T cells.
    Finotello F; Trajanoski Z
    Genome Med; 2017 Jan; 9(1):10. PubMed ID: 28129791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of indirubin on DNA synthesis in vitro].
    Zhang L; Wu GY; Qiu CC; Gao BH
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1985 Apr; 7(2):112-6. PubMed ID: 2936495
    [No Abstract]   [Full Text] [Related]  

  • 18. Metabolic Regulation of Tregs in Cancer: Opportunities for Immunotherapy.
    Wang H; Franco F; Ho PC
    Trends Cancer; 2017 Aug; 3(8):583-592. PubMed ID: 28780935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory T cells and toll-like receptors in cancer therapy.
    Wang RF
    Cancer Res; 2006 May; 66(10):4987-90. PubMed ID: 16707417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunologic management of cancer].
    Unsgård G
    Tidsskr Nor Laegeforen; 1981 Aug; 101(24):1322-6. PubMed ID: 6457419
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.